State of Wisconsin Investment Board
SRPT icon

State of Wisconsin Investment Board’s Sarepta Therapeutics SRPT Stock Holding History

State of Wisconsin Investment Board’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$935K Sell
52,052
-560
-1% -$10.6K ﹤0.01% 1806
2026
Q1 		$1.14M Buy
52,612
+14
+0% +$271 ﹤0.01% 1627
2025
Q4 		$1.13M Sell
52,598
-3,573
-6% -$75.3K ﹤0.01% 1626
2025
Q3 		$1.08M Sell
56,171
-54,293
-49% -$968K ﹤0.01% 1587
2025
Q2 		$1.89M Buy
110,464
+36,245
+49% +$1.55M ﹤0.01% 1325
2025
Q1 		$4.74M Buy
74,219
+12,161
+20% +$1.28M 0.01% 957
2024
Q4 		$7.55M Buy
62,058
+4,198
+7% +$514K 0.02% 784
2024
Q3 		$7.23M Sell
57,860
-7,517
-11% -$1.04M 0.02% 809
2024
Q2 		$10.3M Buy
65,377
+3,829
+6% +$492K 0.03% 569
2024
Q1 		$7.97M Sell
61,548
-3,867
-6% -$474K 0.02% 745
2023
Q4 		$6.31M Sell
65,415
-1,453
-2% -$139K 0.02% 874
2023
Q3 		$8.11M Sell
66,868
-18,122
-21% -$2.05M 0.03% 671
2023
Q2 		$9.73M Sell
84,990
-140
-0.2% -$18.1K 0.03% 617
2023
Q1 		$11.7M Buy
85,130
+4,505
+6% +$584K 0.03% 508
2022
Q4 		$10.4M Sell
80,625
-3,882
-5% -$450K 0.03% 548
2022
Q3 		$9.34M Sell
84,507
-4,747
-5% -$478K 0.03% 599
2022
Q2 		$6.69M Buy
89,254
+14,763
+20% +$1.09M 0.02% 845
2022
Q1 		$5.82M Buy
74,491
+64,323
+633% +$4.93M 0.01% 1080
2021
Q4 		$916K Buy
10,168
+604
+6% +$51.6K ﹤0.01% 1478
2021
Q3 		$884K Buy
9,564
+451
+5% +$34.7K ﹤0.01% 1487
2021
Q2 		$708K Sell
9,113
-55,158
-86% -$4.18M ﹤0.01% 1576
2021
Q1 		$4.79M Sell
64,271
-44,522
-41% -$4.11M 0.01% 1033
2020
Q4 		$18.5M Sell
108,793
-6,417
-6% -$951K 0.04% 439
2020
Q3 		$16.2M Buy
115,210
+28,442
+33% +$4.32M 0.04% 447
2020
Q2 		$13.9M Buy
86,768
+47,785
+123% +$6.5M 0.04% 464
2020
Q1 		$3.81M Sell
38,983
-10,010
-20% -$1.14M 0.01% 885
2019
Q4 		$6.32M Sell
48,993
-816
-2% -$82.4K 0.02% 860
2019
Q3 		$3.75M Buy
49,809
+39,738
+395% +$4.69M 0.01% 887
2019
Q2 		$1.53M Sell
10,071
-2,357
-19% -$286K ﹤0.01% 1060
2019
Q1 		$1.48M Sell
12,428
-345
-3% -$44.4K ﹤0.01% 1059
2018
Q4 		$1.39M Buy
12,773
+730
+6% +$91.3K ﹤0.01% 1045
2018
Q3 		$1.95M Sell
12,043
-30
-0.2% -$4.1K 0.01% 1047
2018
Q2 		$1.6M Sell
12,073
-46,927
-80% -$4.43M ﹤0.01% 1027
2018
Q1 		$4.37M Hold
59,000
– – 0.01% 876
2017
Q4 		$3.28M Buy
59,000
+23,000
+64% +$1.22M 0.01% 913
2017
Q3 		$1.63M Hold
36,000
– – ﹤0.01% 986
2017
Q2 		$1.21M Buy
+36,000
New +$1.17M ﹤0.01% 1025

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

State of Wisconsin Investment Board's SRPT Position: Q2 2026 in Review

State of Wisconsin Investment Board reduced its Sarepta Therapeutics (SRPT) stake by 1.1% in Q2 2026, selling an estimated $10.6K and leaving 52,052 shares worth $935K. The position accounts for ﹤0.01% of the portfolio, ranked #1806.

State of Wisconsin Investment Board first reported a position in SRPT in Q2 2017 and has held it in 37 quarters since. The position peaked at $18.5M in Q4 2020. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • State of Wisconsin Investment Board held 52,052 shares of Sarepta Therapeutics worth $935K as of Q2 2026.
  • State of Wisconsin Investment Board sold 560 Sarepta Therapeutics shares in Q2 2026, an estimated $10.6K.
  • Sarepta Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #1806 holding.
  • State of Wisconsin Investment Board first reported a position in Sarepta Therapeutics in Q2 2017 and has held it in 37 quarters since.
  • State of Wisconsin Investment Board's Sarepta Therapeutics position peaked at $18.5M in Q4 2020.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.